FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vincenzo Altieri

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Sisto Perdonà; Giuseppe Perruolo; Rosa Spinelli; Vincenzo Altieri; Riccardo Autorino; Dario Bruzzese; Rocco Damiano; Marco De Sio; Giuseppe Di Lorenzo; Matteo Ferro; Michele Longo; Ada Marino; Claudia Mazzarella; Andrea Oliva; Daniela Terracciano
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.
Vincenzo Serretta; Rosalinda Allegro; Vincenzo Altieri; Giuseppe Carrieri; Alessandra Di Lallo; Giuseppe Morgia
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma.
Vincenzo Serretta; Rosalinda Allegro; Vincenzo Altieri; Gaetano De Grande; Francesco Ferraù; Rosaria Mazza; Darwin Melloni; Giuseppe Morgia; Federico Nicolosi; Vittorio Gebbia
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vincenzo Altieri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sisto Perdonà; Giuseppe Perruolo; Rosa Spinelli; Vincenzo Altieri; Riccardo Autorino; Dario Bruzzese; Rocco Damiano; Marco De Sio; Giuseppe Di Lorenzo; Matteo Ferro; Michele Longo; Ada Marino; Claudia Mazzarella; Andrea Oliva; Daniela Terracciano
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.
The Prostate 2013;73(3):227-35.
2013: Vincenzo Serretta; Rosalinda Allegro; Vincenzo Altieri; Giuseppe Carrieri; Alessandra Di Lallo; Giuseppe Morgia
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma.
Urology 2013;81(2):277-81.
2012: Vincenzo Serretta; Rosalinda Allegro; Vincenzo Altieri; Gaetano De Grande; Francesco Ferraù; Rosaria Mazza; Darwin Melloni; Giuseppe Morgia; Federico Nicolosi; Vittorio Gebbia
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.
Clinical genitourinary cancer 2012;10(3):174-9.
2012: Matteo Ferro; Vincenzo Macchia; Angela Mariano; Ada Marino; Claudia Mazzarella; Sisto Perdonà; Alessandra Sorrentino; Vincenzo Altieri; Riccardo Autorino; Dario Bruzzese; carlo buonerba; Angelina Di Carlo; Giuseppe Di Lorenzo; Daniela Terracciano
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.
Clinica chimica acta; international journal of clinical chemistry 2012;413(15-16):1274-8.
2012: Matteo Ferro; Gaia Giuberti; Sisto Perdonà; Stefania Porto; Pasquale Sperlongano; Silvia Zappavigna; Alberto Abbruzzese; Vincenzo Altieri; carlo buonerba; Giuseppe Di Lorenzo; Gaetano Facchini; Michele Caraglia
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms.
Oncology reports 2012;27(2):409-15.
2012: Daniela Terracciano; Vincenzo Altieri; Dario Bruzzese; Giuseppe Di Lorenzo; Matteo Ferro; Vincenzo Macchia; Angela Mariano; Claudia Mazzarella; Angelina Di Carlo
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading.
The Prostate 2012;72(1):100-7.
2011: Giuseppe Di Lorenzo; Piera Federico; Matteo Ferro; Ciro Imbimbo; Nicola Longo; Elide Matano; Vincenzo Altieri; Riccardo Autorino; carlo buonerba; Giacomo Cartenì; Carmine D'Aniello; Sabino De Placido; Giovannella Palmieri; Sisto Perdonà; Pasquale Rescigno; Vincenzo Mirone
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study.
European urology 2011;60(6):1280-4.
2011: carlo buonerba; Piera Federico; Carmine D'Aniello; Pasquale Rescigno; Carla Cavaliere; Livio Puglia; Matteo Ferro; Vincenzo Altieri; Sisto Perdonà; Sabino De Placido; Giuseppe Di Lorenzo
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients.
Cancer chemotherapy and pharmacology 2011;67(6):1455-61.
2011: Raffaele Capasso; Gabriella Aviello; Francesca Borrelli; Barbara Romano; Matteo Ferro; Luigi Castaldo; Vittorino Montanaro; Vincenzo Altieri; Angelo A Izzo
Inhibitory effect of standardized cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility.
Urology 2011;77(4):1006.e9-1006.e15.
2011: Giuseppe Di Lorenzo; carlo buonerba; Adriana Faiella; Pasquale Rescigno; Mimma Rizzo; Riccardo Autorino; Sisto Perdonà; Nando Riccardi; Sarah Scagliorini; Florinda Scognamiglio; Daniele Masala; Matteo Ferro; Giovannella Palmieri; Michele Aieta; Alfredo Marinelli; Vincenzo Altieri; Sabino De Placido; Giacomo Cartenì
Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer.
BJU international 2011;107(2):234-9.
2010: Daniela Terracciano; Claudia Mazzarella; Angelina Di Carlo; Angela Mariano; Matteo Ferro; Giuseppe Di Lorenzo; Antonio Giordano; Vincenzo Altieri; Sabino De Placido; Vincenzo Macchia
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content.
Oncology reports 2010;24(1):213-7.
2010: Vincenzo Serretta; Giuseppe Morgia; Vincenzo Altieri; Alessandra Di Lallo; Giovanni Ruggiero; Luigi Salzano; Michele Battaglia; Mario Falsaperla; Aniello Zito; Domenico Sblendorio; Darvinio Melloni; Rosalinda Allegro
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.
BJU international 2010;106(2):212-7.
2009: Sara Simonetti; Rosa Russo; Giuseppe Ciancia; Vincenzo Altieri; Gaetano De Rosa; Luigi Insabato
Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
International journal of surgical pathology 2009;17(3):198-205.
2009: stefania staibano; Massimo Mascolo; Francesco Paolo Mancini; Annamaria Kisslinger; Gaetano Salvatore; Manuela Di Benedetto; Paolo Chieffi; Vincenzo Altieri; Domenico Prezioso; Gennaro Ilardi; Gaetano De Rosa; Donatella Tramontano
Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer.
Histopathology 2009;54(5):580-9.
2009: Giuseppe Di Lorenzo; Giacomo Cartenì; Riccardo Autorino; Antonio Gonnella; Sisto Perdonà; Matteo Ferro; Nicola Longo; Pasquale Rescigno; Francesca Doria; Adriana Faiella; Vincenzo Altieri; Giovannella Palmieri; Ciro Imbimbo; Vincenzo Mirone; Sabino De Placido
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients.
Anti-cancer drugs 2009;20(4):277-80.
2009: Vincenzo Serretta; Vincenzo Altieri; Giuseppe Morgia; Alfredo Siragusa; Gaetano De Grande; Matteo Napoli; Mario Falsaperla; Darwin Melloni; Rosalinda Allegro
Oral chemotherapy in hormone-refractory prostate carcinoma patients unwilling to be admitted to hospital.
Urologia internationalis 2009;83(4):452-7.
2009: Vincenzo Serretta; Vincenzo Altieri; Giuseppe Morgia; Rosalinda Allegro; Antonina Ruggirello; Alessandra Di Lallo; Giuseppe Carrieri; Darwin Melloni
Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma.
Urologia internationalis 2009;82(3):318-23.
2007: Giuseppe Di Lorenzo; Riccardo Autorino; Sisto Perdonà; Michele De Laurentiis; Massimo D'Armiento; Giuseppe Cancello; Vincenzo Mirone; Ciro Imbimbo; Nicola Longo; Vincenzo Altieri; Giampaolo Tortora; William D Figg; Sabino De Placido
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study.
European urology 2007;52(4):1020-7.
2007: Tobias Klatte; Jean-Jacques Patard; Rakhee H Goel; Mark D Kleid; Francois Guille; Bernard Lobel; Claude C Abbou; Alexandre de la Taille; Jacques Tostain; Luca Cindolo; Vincenzo Altieri; Vincenzo Ficarra; Walter Artibani; Tommaso Prayer-Galetti; Ernst Peter Allhoff; Luigi Schips; Richard Zigeuner; Robert A Figlin; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun; John S Lam
Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
The Journal of urology 2007;178(1):35-40; discussion 40.
2007: John S Lam; Tobias Klatte; Jean-Jacques Patard; Rakhee H Goel; François Guillè; Bernard Lobel; Claude C Abbou; Alexandre de la Taille; Jacques Tostain; Luca Cindolo; Vincenzo Altieri; Vincenzo Ficarra; Walter Artibani; Tommaso Prayer-Galetti; Luigi Schips; Richard Zigeuner; Allan J Pantuck; Robert A Figlin; Arie S Belldegrun
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience.
European urology 2007;52(1):155-62.
2007: Pierre I Karakiewicz; Quoc-Dien Trinh; Naeem Bhojani; Karim Bensalah; Laurent Salomon; Alexandre de la Taille; Jacques Tostain; Luca Cindolo; Vincenzo Altieri; Vincenzo Ficarra; Luigi Schips; Richard Zigeuner; Peter F A Mulders; Antoine Valeri; Jean-Luc Descotes; Arnaud Mejean; Jean-Jacques Patard
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
European urology 2007;51(6):1616-24.
2007: Giuseppe Di Lorenzo; Riccardo Autorino; Mario Giuliano; Emilio Morelli; Antonio Giordano; Giorgio Napodano; Aniello Russo; Giulio Benincasa; Massimo D'Armiento; Vincenzo Altieri; Sabino De Placido
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer.
Urology 2007;69(2):347-51.
2006: Vincenzo Altieri
[Fixed points and open questions in the treatment of superficial bladder carcinoma].
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 2006;78(4 Suppl 1):3-5.
2006: Chiara Mignogna; stefania staibano; Vincenzo Altieri; Gaetano De Rosa; Giuseppe Pannone; Angela Santoro; Rosanna Zamparese; Massimo D'Armiento; Romualdo Rocchetti; Ernesto Mezza; Mario Nasti; Viviana Strazzullo; Vittorino Montanaro; Massimo Mascolo; Pantaleo Bufo
Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
BMC cancer 2006;6():293.
2006: Vincenzo Serretta; Giuseppe Morgia; Vincenzo Altieri; Michele Pavone-Macaluso; F Scuto; Rosalinda Allegro; A Di Lallo; Luca Cindolo; Darwin Melloni
Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder. A study from Gruppo Studi Tumori Urologici Foundation.
Urologia internationalis 2006;77(2):152-8.
2005: Vincenzo Ficarra; François Guillè; Luigi Schips; Alexandre de la Taille; Tommaso Prayer-Galetti; Jacques Tostain; Luca Cindolo; Giacomo Novara; Richard Zigeuner; Emiliano Bratti; Guorong Li; Vincenzo Altieri; Claude C Abbou; Luisa Zanolla; Walter Artibani; Jean-Jacques Patard
Proposal for revision of the TNM classification system for renal cell carcinoma.
Cancer 2005;104(10):2116-23.
2005: Monica Cantile; Annamaria Kisslinger; Luca Cindolo; Giulia Schiavo; D'Antò Vincenzo; renato franco; Vincenzo Altieri; A Gallo; A Villacci; Donatella Tramontano; Clemente Cillo
cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers.
Journal of cellular physiology 2005;205(2):202-10.
2005: Luca Cindolo; Jean-Jacques Patard; Paolo Chiodini; Luigi Schips; Vincenzo Ficarra; Jacques Tostain; Alexandre de la Taille; Vincenzo Altieri; Bernard Lobel; Richard Zigeuner; Walter Artibani; François Guillé; Claude C Abbou; Luigi Salzano; Ciro Gallo
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cancer 2005;104(7):1362-71.
2005: Vincenzo Ficarra; Luigi Schips; François Guillè; Guorong Li; Alexandre de la Taille; Tommaso Prayer-Galetti; Luca Cindolo; Giacomo Novara; Richard Zigeuner; Emiliano Bratti; Jacques Tostain; Vincenzo Altieri; Claude C Abbou; Walter Artibani; Jean-Jacques Patard
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma.
Cancer 2005;104(5):968-74.
2005: Raffaele Capasso; Francesca Borrelli; Vittorino Montanaro; Vincenzo Altieri; Francesco Capasso; Angelo A Izzo
Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility.
The Journal of urology 2005;173(6):2194-7.
2005: Massimo Mascolo; Vincenzo Altieri; Chiara Mignogna; Giorgio Napodano; Gaetano De Rosa; Luigi Insabato
Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report.
BMC cancer 2005;5():88.
2004: Giuseppe Di Lorenzo; Carmine Pizza; Riccardo Autorino; Michele De Laurentiis; Ombretta Marano; Adele D'Alessio; Giuseppe Cancello; Vincenzo Altieri; Giampaolo Tortora; Sisto Perdonà; Angelo Raffaele Bianco; Sabino De Placido
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer.
European urology 2004;46(6):712-6.
2004: Domenico Prezioso; Giuseppe Piccirillo; Rocco Galasso; Vincenzo Altieri; Vincenzo Mirone; Tullio Lotti
Gynecomastia due to hormone therapy for advanced prostate cancer: a report of ten surgically treated cases and a review of treatment options.
Tumori 2004;90(4):410-5.
2004: Luca Cindolo; Emiliano A Palmieri; Riccardo Autorino; Luigi Salzano; Vincenzo Altieri
Standard versus hydrophilic catheterization in the adjuvant treatment of patients with superficial bladder cancer.
Urologia internationalis 2004;73(1):19-22.
2004: Leo Romis; Luca Cindolo; Jean-Jacques Patard; Giovanni Messina; Vincenzo Altieri; Laurent Salomon; Claude C Abbou; Dominique Chopin; Bernard Lobel; Alexandre de la Taille
Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database.
European urology 2004;45(1):53-7; discussion 57.
2003: Luca Cindolo; Alexandre de la Taille; G Messina; L Romis; Claude C Abbou; Vincenzo Altieri; Alejandro Remigio Rodriguez; Jean-Jacques Patard
A preoperative clinical prognostic model for non-metastatic renal cell carcinoma.
BJU international 2003;92(9):901-5.
2003: Monica Cantile; Luca Cindolo; Giorgio Napodano; Vincenzo Altieri; Clemente Cillo
Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas.
Oncogene 2003;22(41):6462-8.
2003: Dario Musone; Luca Cindolo; Vincenzo Altieri; DOMENICO RUSSO
[Erectile dysfunction in kidney transplanted patients].
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003;55(3):193-7.
2001: Luca Cindolo; Monica Cantile; Rocco Galasso; M Marsicano; Giorgio Napodano; Vincenzo Altieri
Not traditional prognostic factors in human conventional renal carcinoma.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2001;53(4):211-9.
2001: Luca Cindolo; Giulio Benincasa; Riccardo Autorino; S Domizio; Gaetano De Rosa; G Testa; Massimo D'Armiento; Vincenzo Altieri
Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study.
Oncology reports 2001;8(2):269-71.
1999: Luca Cindolo; A Rega; M Marsicano; A Ginestra; V Guadagno; Vincenzo Altieri
["Classic" vs autolubricant catheterization for endovesicular chemotherapy. Preliminary experience].
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 1999;51(3):181-5.
1999: Luca Cindolo; G Benvenuto; Paola Salvatore; Raffaela Pero; Giuliana Salvatore; Vincenzo Mirone; Domenico Prezioso; Vincenzo Altieri; Carmelo B Bruni; Lorenzo Chiariotti
galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas.
International journal of cancer. Journal international du cancer 1999;84(1):39-43.
1994: Vincenzo Altieri; P Setola; N Ottaviano; G Ucciero; G Scognamiglio; V Montanaro; R Giannella; A Rega; Tullio Lotti
[Imaging diagnosis of non-lymph node metastasis of bladder carcinoma].
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 1994;66(5):223-8.
1990: Tullio Lotti; Vincenzo Altieri; Vincenzo Mirone; N Ottaviano; A Russo
Local hyperthermia for treatment of advanced prostatic carcinoma: preliminary results.
Advances in experimental medicine and biology 1990;267():525-9.